They suggested that secondary hyperparathyroidism, which occurs as a consequence of age, could induce the inhibition of osteoblast proliferation by production of IGFBP-4 in the locale of bone-remodeling sites. This evidence concerns the gene IGFBP4 and secondary hyperparathyroidism.